FOR RESEARCH & EDUCATIONAL PURPOSES ONLY - NOT MEDICAL ADVICE
PeptaBaseBack to Database
Immune Modulation

KPV

Typical Dosage
Oral: 500 mcg Injection: 200-500 mcg
Administration
Oral • Injection
Half-Life
Often cited around 1-2 hours, but robust human PK data are limited

Mechanism of Action

Gut inflammation models|Dermatology/topical studies|Antimicrobial peptide research|IBD-related signaling

Research Protocol Summary

Evidence Level
Preclinical
Species Studied
Mouse • Rat
Administration Schedule
Daily

Studies

Research Availability

Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.

Open PubMed Search
Related resources
Immune ModulationEditorial PolicyEvidence MethodologyResearch GlossaryPeptide ComparisonsPeptide Calculator

Research Feedback

0 approved

For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.

Loading approved insights…

Related Peptides

ARA-290
Immune Modulation
Glutathione
Immune Modulation
LL-37
Immune Modulation
Thymosin Alpha-1
Immune Modulation